Aprea Therapeutics News

Aprea Therapeutics | DEFA14A: Others

Apr 25 19:20

Aprea Therapeutics | DEF 14A: Definitive information statements

Apr 25 19:05

Aprea Therapeutics | 8-K: Current report

Apr 11 04:19

Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 4 04:11

Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Mar 26 20:19

Aprea Therapeutics | 8-K: Current report

Mar 13 04:35

Aprea Therapeutics | 8-K: Current report

Feb 7 06:03

Aprea Therapeutics | 8-K: Current report

Feb 3 05:32

Aprea Therapeutics | 8-K: Current report

Jan 26 20:18

Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jan 26 19:09

Aprea Therapeutics | 8-K: Current report

Jan 4 13:00

Aprea Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 10, 2023 05:20

Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

Nov 10, 2023 05:15

Aprea Therapeutics | 8-K: Current report

Oct 17, 2023 05:29

Aprea Therapeutics | 8-K: Current report

Oct 13, 2023 19:31

Aprea Therapeutics | 8-K: Current report

Sep 11, 2023 20:30

Aprea Therapeutics | 8-K: Current report

Aug 24, 2023 20:00

Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations

Aug 10, 2023 19:36

Aprea Therapeutics | DEF 14A: Definitive information statements

Jul 11, 2023 19:30

Aprea Therapeutics | 8-K: Current report

Jul 6, 2023 04:01